Skip to main content

Table 1 Clinicopathological characteristics of the NSCLC cohort

From: Membranous CD24 expression as detected by the monoclonal antibody SWA11 is a prognostic marker in non-small cell lung cancer patients

 

AC

SCC

N (%)

N (%)

Tumour stage (pT)

   
 

1

29 (21.2 %)

5 (3.6)

 

2

51 (37.2 %)

23 (16.8 %)

 

3

6 (4.4 %)

6 (4.4 %)

 

4

1 (0.7 %)

0 (0 %)

Nodal Status (pN)

0

37 (27.0 %)

15 (10.9 %)

 

1

15 (10.9 %)

9 (6.6 %)

 

2

14 (10.2 %)

3 (2.2 %)

 

3

1 (0.7 %)

0 (0.0 %)

Grading (G)

1

5 (3.6 %)

0 (0.0 %)

 

2

41 (29.9 %)

16 (11.6 %)

 

3

44 (32.1 %)

17 (12.4 %)

Mean age at surgery

 

64,2

64,56

(median age)

 

(65)

(67)

Sex (m:w)

 

68:34

30:5

Median OS (months)

 

52

24

(SD; 95 % CI [months])

 

(±23.7; 5.5– 98.5)

(± 12.8;0.0– 49.0)

  1. SD standard deviation; CI confidence interval; n number of cases; OS overall survival